Papers

2

Total Citations

13

H-Index

2

About

Dr. Bas L. Weusten is a leading figure in minimally invasive surgical oncology, with a primary focus on advancing the treatment of esophageal and gastric cancers. His major contributions lie in the implementation and refinement of robot-assisted techniques, particularly for complex, multiquadrant procedures. Dr. Weusten’s work has been instrumental in demonstrating the safety and feasibility of Robot-Assisted Minimally Invasive Esophagectomy (RAMIE) with three-field lymphadenectomy, even in challenging cases involving cervical lymph node metastasis following neoadjuvant chemoradiotherapy. His research, including a pivotal 2023 study on this topic (11 citations), provides critical evidence for expanding surgical candidacy and improving oncologic outcomes. More recently, he has led the structured implementation of Robot-Assisted Minimally Invasive Gastrectomy (RAMIG) for gastric cancer at a European tertiary referral center, establishing a reproducible protocol for adopting advanced surgical platforms like the DaVinci Xi. By systematically evaluating the integration of these technologies, Dr. Weusten is shaping the future of minimally invasive upper GI surgery, offering patients less invasive options with the potential for better recovery and long-term results.

Research Focus

Key Achievements

2
H-Index
2
Papers
13
Total Citations
7
Avg Citations/Paper
🏆 Most Cited Paper
Safety and Feasibility of Robot-Assisted Minimally Invasive Esophagectomy (RAMIE) with Three-Field Lymphadenectomy and Neoadjuvant Chemoradiotherapy in Patients with Resectable Esophageal Cancer and Cervical Lymph Node Metastasis
11 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 14
🏛 Institutions: University Medical Center Utrecht, St. Antonius Ziekenhuis

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago